Design of a mucin-selective protease for targeted degradation of cancer-associated mucins - Nature Biotechnology

  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Design of a mucin-selective protease for targeted degradation of cancer-associated mucins - KayvonPedram CarolynBertozzi

cells were washed three times with warmed PBS, incubated for 1–2 h in serum-free RPMI without phenol red and without glutamine and resuspended in the same medium at 0.8 × 10cells per ml. αHER2-eStcE, eStcE, StcE or equal volume PBS was added to a final concentration of 1 nM, and the cells were incubated overnight at 37 °C. Cells were centrifuged at 600for 5 min, and conditioned supernatant was collected and treated with protease inhibitors and 10 mM EDTA.

Pellets were resuspended in 100 µl of 6 M guanidine hydrochloride, and protein amounts were determined by a bicinchoninic acid protein assay kit ; 125 µg of total protein material was used for each sample, and samples were adjusted to a total volume of 175 µl with water. Samples were then adjusted to 100 mM HEPES before adding freshly prepared TCEP to a final concentration of 10 mM and incubating at 37 °C for 30 min.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 231. in HEALTH

Health Health Latest News, Health Health Headlines